Brief: Promore Pharma Q1 Operating Loss Narrows To SEK 5.5 Mln
May 21 (Reuters) - Promore Pharma AB PROMO.ST :
* (PUBL) INTERIM REPORT JANUARY - MARCH 2019
* Q1 OPERATING LOSS FOR PERIOD WAS 5.5 (LOSS 7.9) MSEK
* Q1 NET SALES AMOUNTED TO SEK 0.5 MILLION VERSUS SEK 0.1
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr1xQDVL
Further company coverage: PROMO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PMD Device Solutions AB
See all newsBrief: PMD Device Solutions Files For Bankruptcy
Brief: PMD Device Solutions Q3 EBITDA Loss Widens To SEK 8.9 Mln
Brief: Pmd Device Solutions Completes Sale Of Coala Life Monitor
Brief: PMDS’ Largest Shareholder Requests EGM To Appoint New Non-Executive Directors
Brief: PMDS Says RespiraSense Technology Demonstrates Capability In Predicting 7-Day Mortality